December 2010- Volume 6, Issue 12
December 2010
In this Issue
Research & Development
Making a splash
Making a splash
Kadmon Pharmaceuticals, a new player in the biopharmaceutical landscape, is making deals
True relief with sustained release
True relief with sustained release
SurModics and Edge Therapeutics team up to develop sustained-release, site-specific neurological to fend off complications after subarachnoid hemorrhage
Q&A with the stem cell case plaintiffs
Q&A with the stem cell case plaintiffs
Dr. James L. Sherley and Dr. Theresa Deisher share their thoughts about embryonic stem cell research and why they oppose President Obama's order to reinstate federal funding for eSC work
The shot(s) heard ’round the world
The shot(s) heard ’round the world
Hikma expands its global injectables business through the acquisition of Baxter Healthcare’s Multi-Source injectables business
Mouse model message
Mouse model message
Autism Speaks, SAGE Labs collaborate on plan to develop knockout rat models targeted toward treating autism
Stem cell controversy rages on
Stem cell controversy rages on
Plaintiffs in case assert beliefs about embryonic stem cell research as final briefs are filed in federal lawsuit
Diagnostics
A bio duo
A bio duo
bioMérieux and Biocartis sign strategic partnership in flexible molecular diagnostics
Tripartite alliance
Tripartite alliance
Quintiles, Dako and AstraZeneca aim to speed development of personalized medicine
No fish story
No fish story
UK Yorkshire Cancer Research Lab says luminous jellyfish cells help diagnose cancer
Yin and yang
Yin and yang
GE Healthcare acquires cancer diagnostic company Clarient Inc.
Instruments & Informatics
Sequencing evolution
Sequencing evolution
Roche partners with DNA Electronics to develop semiconductor-based sequencing system
Image is everything
Image is everything
PerkinElmer and LinaTech to provide imaging subsystems for cancer treatment
Lane to lane, run to run
Lane to lane, run to run
Caliper turns to Sony Blu-ray technology for expedited microfluidics workflow
Portal opens ways for smoother workflows
Portal opens ways for smoother workflows
Perceptive Informatics enhances its eClinical platform with IBM technologies
Omics & Systems Biology
Genomic sequencing gets ready to take off
Genomic sequencing gets ready to take off
1000 Genomes Project publishes analysis of pilot-phase work and prepares to launch next steps with help of companies like Affymetrix, Illumina, Life Technologies and 454 Life Sciences
A one-in-a-thousand genome
A one-in-a-thousand genome
Oppenheimer Foundation to direct sequencing of first human genome in PGP-1K Project
Zeroing in on Huntington’s
Zeroing in on Huntington’s
Alnylam, Medtronic and CHDI Foundation form collaboration to advance RNAi therapeutic for Huntington’s disease
Bonded by BORG
Bonded by BORG
miRagen Therapeutics signs research, licensing agreements with University of Colorado for microRNA profiling of human heart failure
Testing microRNAs on Horizon
Testing microRNAs on Horizon
Mirna Therapeutics will use Horizon Discovery’s X-MAN models to test activities of its tumor suppressor miRNAs
Global News
A DREAM alliance in pain management
A DREAM alliance in pain management
Evotec and Apeiron Biologics build pain alliance around key molecule for pain regulation
License to research
License to research
Compugen licenses novel oncology target to Seattle Genetics
BMS builds bridges
BMS builds bridges
Bristol-Myers Squibb taps Chinese partner to develop early-stage oncology compound
Chinese take-out
Chinese take-out
China CDC signs agreement with Fred Hutchinson Center to address infectious disease and cancer research
MacroGenics hits winning target
MacroGenics hits winning target
Biotech firm’s DART antibody technology nabs potential $2.1 billion deal with Boehringer Ingelheim
Contract Services
Venn Life Sciences completes acquisition of DCI France
Venn Life Sciences completes acquisition of DCI France
Addition expands Venn’s clinical trial management services in Europe
Eager for the east
Eager for the east
HUYA, Quintiles to co-develop new cancer drug sourced in China
PPD expands investigator network in India
PPD expands investigator network in India
Large investigator site aims to provide clients with faster patient enrollment and reduced time to approval
Off to the CRO races
Off to the CRO races
Horizon Discovery acquires Hypoxium, launches Horizon Discovery Services
Feature
Bringing it together
Bringing it together
LabAutomation2011 in Palm Springs will mark the first large gathering of members under the new SLAS banner
Commentary
Publisher’s note: A look at the ddn’s top five stories of 2010
Publisher’s note: A look at the ddn’s top five stories of 2010
Out of all of our print and online news coverage, we have picked five stories that we feel illustrate some high points and show how ddn is unique in reporting industry news
What is analytical chemistry?
What is analytical chemistry?
We analytical chemists continue to have a variety of concerns about what we do, and those concerns vary with the context of where we do it. The argument stems from confusion over the worthiness of providing a service and whether that can ever fit our definition of science.
New generation of sequencing technologies can replace quantitative PCR in mainstream R&D
New generation of sequencing technologies can replace quantitative PCR in mainstream R&D
The most powerful advance in genomics of the last five years has taken place in DNA sequencing technology. Capillary and gel-based Sanger sequencing has been superseded by new massively parallel approaches that offer several orders of magnitude greater sequencing capacity, at >500-fold reduction in cost per base.
Special Reports
Financing the fight
Financing the fight
Foundations are at ground zero in the battle against cancer
Pink ribbons and yellow bracelets
Pink ribbons and yellow bracelets
The strange paradox of cancer’s persistence in the face of public optimism about progress toward a cure
